The Nation - News from July 25, 1989

A New York pharmaceutical company recalled a generic anti-hypertensive drug because it said company employees misrepresented samples of the drug submitted for government inspection. Par Pharmaceutical Inc. of Spring Valley, N.Y., also said it suspended sales of two other government-approved drugs while investigations into them continue. The recall of Par’s generic version of the high-blood-pressure drug Maxzide marks the second time this summer a drug company has informed the Food and Drug Administration it had misrepresented its product to the agency. In each case, the companies marketed formulations of their product that were different than those approved by the FDA.